Abstract

BackgroundCurrently, the appropriate method of management of patients with refractory septic shock remains unclear. This study aimed to evaluate the factors associated with response to epinephrine in norepinephrine-refractory septic shock.MethodsA retrospective single-center observational study was performed using data from adult patients (≥ 18 years old) admitted to our emergency and medical intensive care unit (ICU) from January 2014 to December 2017 who had received epinephrine to treat norepinephrine-refractory septic shock. The response was considered positive if there was increase in mean arterial pressure of 10 mmHg or decrease in arterial lactate level 3 h after epinephrine administration.ResultsForty-one patients were included: 24 responders (59%) and 17 non-responders (41%). Responders showed higher rate of survival from shock (92% vs. 18%; P < 0.001), and 28-day survival (83% vs. 18%; P < 0.001). In multivariable analysis, time of epinephrine administration after ICU admission (odds ratio [OR] 0.48; 95% confidence interval [CI] 0.27–0.87; P = 0.011) and SOFA score (OR 0.19; 95% CI 0.04–0.88; P = 0.034) were associated with epinephrine response. Time of epinephrine administration was also significantly associated with survival from shock (OR 0.42; P = 0.005) and 28-day survival (OR 0.14; P = 0.006), while SOFA score did not. Using inverse probability of treatment weighing (IPTW) adjustment of propensity score, epinephrine administration later than 24 h after ICU admission was associated with poor response (OR 0.07; 95% CI 0.02–0.21; P < 0.001).ConclusionsEarly administration of epinephrine after ICU admission (i.e., within 24 h) is associated with better hemodynamic status in patients with refractory septic shock.

Highlights

  • The appropriate method of management of patients with refractory septic shock remains unclear

  • Refractory shock is defined as resistance to the standard dose of norepinephrine administered as a first-line vasopressor [1] and is the major reason for death among patients with sepsis or septic shock [2]

  • Le Tulzo et al showed that epinephrine improves right ventricular contractility in septic shock patients who are unresponsive to dobutamine

Read more

Summary

Introduction

The appropriate method of management of patients with refractory septic shock remains unclear. This study aimed to evaluate the factors associated with response to epinephrine in norepinephrinerefractory septic shock. A couple of guidelines suggest treatment options, including the use of epinephrine, for patients with septic shock who are refractory to norepinephrine [6, 7]. Epinephrine was previously shown to have some beneficial effects against refractory septic shock in rats [8]. Le Tulzo et al showed that epinephrine improves right ventricular contractility in septic shock patients who are unresponsive to dobutamine (2019) 7:20. [9], while Mahmoud et al, in a randomized control trial, showed that compared to dobutamine, epinephrine effectively improved mean arterial pressure (MAP) and cardiac index in 60 septic shock patients resistant to norepinephrine [10]. Other large randomized controlled trials did not find epinephrine to be superior to other vasopressors or inotropic agents [11, 12]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call